<DOC>
	<DOCNO>NCT00384280</DOCNO>
	<brief_summary>An open label , 2-period , sequential study determine impact multiple dos rifampin single-dose pharmacokinetics HCV-796</brief_summary>
	<brief_title>Study Determine Impact Multiple Doses Rifampin Single-dose Pharmacokinetics HCV-796</brief_title>
	<detailed_description />
	<mesh_term>Rifampin</mesh_term>
	<criteria>Healthy determine investigator basis medical history , physical examination , clinical laboratory test result , vital sign , 12lead electrocardiogram ( ECG ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>